Previous 10 | Next 10 |
Search all articles related articles and news articles from the OTCMKTS NASDAQ and NYSE markets.
Stifel analyst Nathan Jones reiterated a Buy rating on the shares of Xylem Inc (NYSE: XYL) with a price target of $133. Wi...
The Walt Disney Co (NYSE: DIS) is now on the offensive, countering the board appointed by Governor Ron DeSantis, connected to its Fl...
Truist Securities analyst Jake Bartlett reiterated a Buy rating on the shares of The Wendy's Co (NASDAQ: WEN) with a p...
Truist Securities analyst Jake Bartlett reiterated a Buy rating on the shares of The Wendy's Co (NASDAQ: WEN) with a p...
Truist Securities analyst Jake Bartlett reiterated a Buy rating on the shares of The Wendy's Co (NASDAQ: WEN) with a p...
President Joe Biden is currently hosting South Korean President Yoon Suk Yeol and Japanese Prime Minister Fumio Kishida at Camp David. While there&...
Roots Analysis has done a detailed study on “Global Cell Cytometry Market: Focus on High Throughput Flow Cytometry and Image Cytometry, 2022-2035”.
The growing pipeline of biologics and challenges associated with their manufacturing have prompted stakeholders in the biopharmaceutical industry to adopt cell free expression systems for effective synthesis of biotherapeutics.
LQR House (NasdaqGM: LQR) stock's weakness following its milestone IPO presents a value investment proposition worth considering. The stock initially surged over 40%
LQR House (NasdaqGM: LQR) scored a major milestone last week, securing a listing on the NasdaqGM. While shares have zig-zagged since, the over 40% surge...
News, Short Squeeze, Breakout and More Instantly...
Trending Stock
10.66%Change Percent:
ADiTx Therapeutics Inc. Company Name:
ADTX Stock Symbol:
NASDAQ Market:
aditxt.com Website: